RSS

migraine

Two recently published clinical studies have demonstrated a new approach using antibodies to target specific chemicals in the brain may help significantly reduce the incidence and severity of migraines. more

News

Injectable migraine treatment, ZEMBRACESymTouch (sumatriptan succinate) by Dr Reddy’s Laboratories, has received US Food and Drug Administration (FDA) approval more

News